Dr. Novack Presents Clinical Research and FDA Insights at Napa Eye 2026
Dr. Novack presented multiple sessions at Napa Eye 2026, including research on novel ophthalmic medications and a lecture on FDA marketing authorization for ophthalmic drugs and devices.
Dr. Novack Attends ARVO 2026 Annual Meeting in Denver
Dr. Gary Novack attended the 2026 ARVO Annual Meeting in Denver, continuing a tradition of more than 40 years participating in one of ophthalmology’s leading scientific conferences. During the meeting, he presented research on FDA review times and a novel investigational treatment for pterygia while connecting with colleagues and collaborators in vision science.